INCHEON, South Korea, Jan. 15, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its latest business ...
Some results have been hidden because they may be inaccessible to you